Stocks and Investing
Stocks and Investing
Tue, February 1, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Sharpe Maintained (BAH) at Buy with Decreased Target to $93 on, Feb 1st, 2022
Matthew Sharpe of Morgan Stanley, Maintained "Booz Allen Hamilton Holding Corporation" (BAH) at Buy with Decreased Target from $98 to $93 on, Feb 1st, 2022.
Matthew has made no other calls on BAH in the last 4 months.
There are 4 other peers that have a rating on BAH. Out of the 4 peers that are also analyzing BAH, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Matthew
- Brian Gesuale of "Raymond James" Upgraded from Hold to Buy and Held Target at $90 on, Monday, January 31st, 2022
- Ronald Epstein of "B of A Securities" Downgraded from Strong Buy to Sell and Decreased Target to $80 on, Monday, January 31st, 2022
- David Strauss of "Barclays" Upgraded from Hold to Buy and Increased Target to $105 on, Monday, January 24th, 2022
- Matthew Akers of "Wells Fargo" Maintained at Buy with Increased Target to $99 on, Monday, November 1st, 2021
Contributing Sources